Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders ...

Collaborative discussions” with the FDA encouraged Praxis to submit early next year an approval filing for its epilepsy drug. Elsewhere, Rezolute shares plunged and Centessa announced a new CEO.

International Community Health Services (ICHS) has launched Together We Rise, a wellness podcast with useful information ...

Happiness isn’t a finish line. Learn what science says actually builds well-being and how small, practical shifts can make a real difference.